Prothena Corp. Plc (PRTA)
9.86
+0.50
(+5.34%)
USD |
NASDAQ |
Mar 04, 16:00
9.84
-0.02
(-0.20%)
After-Hours: 20:00
Prothena Cash from Investing (TTM) : -0.1423M for Dec. 31, 2025
Cash from Investing (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (TTM) Benchmarks
| Novo Nordisk A/S | -12.02B |
| Amarin Corp. Plc | -- |
| Jazz Pharmaceuticals Plc | -1.510B |
| Iterum Therapeutics Plc | 0.6541M |
| GH Research Plc | 59.02M |